UPDATE: April 29, 2021 – Second lot recalled due to presence of nitrosamine impurity Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after ...
Amitriptyline is a prescription drug available as a tablet in several strengths. It’s approved for use to treat depression but is also often prescribed for several other conditions like pain, ...
Amitriptyline can significantly improve symptoms of irritable bowel syndrome (IBS), according to a study led by the universities of Leeds, Southampton, and Bristol. The researchers urged that the ...
Researchers conducted a pragmatic, randomized, placebo-controlled, phase 3 trial, in collaboration with 64 general practices in Amsterdam, to evaluate the effectiveness of low doses of the ...
Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets after testing identified levels of N-nitrosodimethylamine (NDMA) above what is considered acceptable if the drug were to be taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results